Granules India gains key FDA approval for Unit V facility, marking major compliance milestone

Granules India gains key FDA approval for Unit V facility, marking major compliance milestone

Hyderabad-based Granules India Limited has achieved a significant regulatory milestone, securing an Establishment Inspection Report (EIR) with a “No Action Indicated” (NAI) status from the U.S. Food and Drug Administration (FDA) for its Unit V facility in Jawaharlal Nehru Pharma City, Andhra Pradesh. The pharmaceutical firm received the EIR following a comprehensive inspection held in […]